{"id":956675,"date":"2026-04-30T09:25:06","date_gmt":"2026-04-30T13:25:06","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/"},"modified":"2026-04-30T09:25:06","modified_gmt":"2026-04-30T13:25:06","slug":"sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/","title":{"rendered":"SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024"},"content":{"rendered":"<p>        <!--.bwalignc { text-align: center; list-style-position: inside }body {font:normal small Arial,Helvetica,sans-serif;color:#000;background-color:#fff;padding:24px;margin:0;} a img {border:0;} h3 {font-size:medium;color:#000;margin:0 0 1em 0; text-align:center;}-->  <\/p>\n<p class=\"bwalignc\"><b>SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024<\/b><\/p>\n<p>BEIJING&#8211;(<a href=\"http:\/\/www.businesswire.com\">BUSINESS WIRE<\/a>)&#8211;<br \/>\nSinovac Biotech Ltd. (Nasdaq: SVA) (\u201cSINOVAC\u201d or the \u201cCompany\u201d), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the \u201cAnnual Report\u201d) with the U.S. Securities and Exchange Commission (\u201cSEC\u201d). An electronic copy of the Annual Report can be accessed on SINOVAC\u2019s investor relations website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sinovac.com%2Fen-us%2FInvestors&amp;esheet=54525942&amp;newsitemid=20260429934070&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.sinovac.com%2Fen-us%2FInvestors&amp;index=1&amp;md5=e59383ef4a465bb8fd70c2ddd4e56247\"><i>https:\/\/www.sinovac.com\/en-us\/Investors<\/i><\/a> and on the SEC\u2019s website at <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sec.gov&amp;esheet=54525942&amp;newsitemid=20260429934070&amp;lan=en-US&amp;anchor=www.sec.gov&amp;index=2&amp;md5=cfc9efe486eba5be16399048b33d24b4\"><i>www.sec.gov<\/i><\/a>.<\/p>\n<p><b>About SINOVAC<\/b><\/p>\n<p>\nSinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of \u201csupply vaccines to eliminate human diseases\u201d, the company specializes in the research, development, manufacturing and commercialization of vaccines and related biological products that protect against human infectious diseases.<\/p>\n<p>\nThe company\u2019s diversified portfolio includes vaccines for influenza, viral hepatitis, varicella, Hand-Foot-Mouth disease (HFMD), poliomyelitis, pneumococcal disease, etc., of which 3 vaccines have been prequalified by WHO, including inactivated hepatitis A vaccine Healive<sup>\u00ae<\/sup>, Sabin-strain inactivated polio vaccine (sIPV), and varicella vaccine.<\/p>\n<p>\nSINOVAC has a leading edge in developing vaccines to combat infectious disease outbreaks and was among the first to initiate R&amp;D during major public health emergencies, including SARS, H5N1, H1N1, and COVID-19. The company developed the world\u2019s first inactivated SARS vaccine (Phase I completed), China\u2019s first H5N1 influenza vaccine (Panflu<sup>\u00ae<\/sup>), the world\u2019s first H1N1 influenza vaccine (Panflu.1<sup>\u00ae<\/sup>), and CoronaVac<sup>\u00ae<\/sup>, the most widely used inactivated COVID-19 vaccine globally.<\/p>\n<p>\nBeyond its marketed portfolio, the company is advancing a robust pipeline that includes combination vaccines, recombinant protein vaccines and next-generation platforms such as mRNA technologies and antibodies.<\/p>\n<p>\nWith a long-standing commitment to innovation and global health, SINOVAC is expanding its global footprint by strengthening partnerships with research institutions, international organizations, and local partners. Through broader market presence, technological cooperation, and localized production, the company aims to accelerate vaccine development and supply, enhance regional access to high-quality products, and better address unmet medical needs while improving preparedness for future pandemics.<\/p>\n<p>\nFor more information, please see the Company\u2019s website at <i><a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sinovac.com&amp;esheet=54525942&amp;newsitemid=20260429934070&amp;lan=en-US&amp;anchor=www.sinovac.com&amp;index=3&amp;md5=4079976bd98088f8e205f01c65ebfea6\">www.sinovac.com<\/a><\/i>.<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260429934070r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" style=\"width:0;height:0\" \/><span class=\"bwct31415\" \/><\/p>\n<p id=\"mmgallerylink\"><span id=\"mmgallerylink-phrase\">View source version on businesswire.com: <\/span><span id=\"mmgallerylink-link\"><a href=\"https:\/\/www.businesswire.com\/news\/home\/20260429934070\/en\/\" rel=\"nofollow\">https:\/\/www.businesswire.com\/news\/home\/20260429934070\/en\/<\/a><\/span><\/p>\n<p>\nInvestor and Media Contact<br \/>\n<br \/>Sinovac Biotech Ltd.<br \/>\n<br \/>Email: <a rel=\"nofollow\" href=\"mailto:ir@sinovac.com\">ir@sinovac.com<\/a><\/p>\n<p><b>KEYWORDS:<\/b> China Asia Pacific<\/p>\n<p><b>INDUSTRY KEYWORDS:<\/b> Biotechnology Infectious Diseases COVID-19 Health Pharmaceutical<\/p>\n<p><b>MEDIA:<\/b><\/p>\n<table cellpadding=\"3\" cellspacing=\"3\" \/>\n","protected":false},"excerpt":{"rendered":"<p>SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 BEIJING&#8211;(BUSINESS WIRE)&#8211; Sinovac Biotech Ltd. (Nasdaq: SVA) (\u201cSINOVAC\u201d or the \u201cCompany\u201d), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the \u201cAnnual Report\u201d) with the U.S. Securities and Exchange Commission (\u201cSEC\u201d). An electronic copy of the Annual Report can be accessed on SINOVAC\u2019s investor relations website at https:\/\/www.sinovac.com\/en-us\/Investors and on the SEC\u2019s website at www.sec.gov. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of \u201csupply vaccines to eliminate human diseases\u201d, the company specializes in the research, development, manufacturing and commercialization of vaccines and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-956675","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 BEIJING&#8211;(BUSINESS WIRE)&#8211; Sinovac Biotech Ltd. (Nasdaq: SVA) (\u201cSINOVAC\u201d or the \u201cCompany\u201d), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the \u201cAnnual Report\u201d) with the U.S. Securities and Exchange Commission (\u201cSEC\u201d). An electronic copy of the Annual Report can be accessed on SINOVAC\u2019s investor relations website at https:\/\/www.sinovac.com\/en-us\/Investors and on the SEC\u2019s website at www.sec.gov. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of \u201csupply vaccines to eliminate human diseases\u201d, the company specializes in the research, development, manufacturing and commercialization of vaccines and &hellip; Continue reading &quot;SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-30T13:25:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260429934070r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024\",\"datePublished\":\"2026-04-30T13:25:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\\\/\"},\"wordCount\":405,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260429934070r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\\\/\",\"name\":\"SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260429934070r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"datePublished\":\"2026-04-30T13:25:06+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\\\/#primaryimage\",\"url\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260429934070r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\",\"contentUrl\":\"https:\\\/\\\/cts.businesswire.com\\\/ct\\\/CT?id=bwnews&amp;sty=20260429934070r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/","og_locale":"en_US","og_type":"article","og_title":"SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 - Market Newsdesk","og_description":"SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 BEIJING&#8211;(BUSINESS WIRE)&#8211; Sinovac Biotech Ltd. (Nasdaq: SVA) (\u201cSINOVAC\u201d or the \u201cCompany\u201d), a leading provider of biopharmaceutical products in China, today announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2024 (the \u201cAnnual Report\u201d) with the U.S. Securities and Exchange Commission (\u201cSEC\u201d). An electronic copy of the Annual Report can be accessed on SINOVAC\u2019s investor relations website at https:\/\/www.sinovac.com\/en-us\/Investors and on the SEC\u2019s website at www.sec.gov. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based global biopharmaceutical company, with a mission of \u201csupply vaccines to eliminate human diseases\u201d, the company specializes in the research, development, manufacturing and commercialization of vaccines and &hellip; Continue reading \"SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/","og_site_name":"Market Newsdesk","article_published_time":"2026-04-30T13:25:06+00:00","og_image":[{"url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260429934070r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024","datePublished":"2026-04-30T13:25:06+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/"},"wordCount":405,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260429934070r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/","name":"SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/#primaryimage"},"thumbnailUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260429934070r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","datePublished":"2026-04-30T13:25:06+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/#primaryimage","url":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260429934070r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en","contentUrl":"https:\/\/cts.businesswire.com\/ct\/CT?id=bwnews&amp;sty=20260429934070r1&amp;sid=flmnd&amp;distro=nx&amp;lang=en"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/sinovac-files-annual-report-on-form-20-f-for-the-fiscal-year-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/956675","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=956675"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/956675\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=956675"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=956675"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=956675"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}